We are live on
!
Find out more
FA
Fagan Associates Portfolio holdings
AUM
$719M
1-Year Est. Return
26.65%
This Fund
S&P 500
This Quarter
Est. Return
-3.8%
1 Year Est. Return
+26.65%
3 Year Est. Return
+87.69%
5 Year Est. Return
+107.31%
10 Year Est. Return
+467.14%
AUM
$136M
AUM Growth
-$13.4M
(-9%)
Cap. Flow
-$6.34M
Cap. Flow
% of AUM
-4.65%
Top 10 Holdings %
Top 10 Hldgs %
37.54%
Holding
98
New
5
Increased
53
Reduced
26
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.11M |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.09M |
| 3 |
Vanguard Total Bond Market
BND
|
+$704K |
| 4 |
Tanger
SKT
|
+$631K |
| 5 |
Jack in the Box
JACK
|
+$439K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$7.34M |
| 2 |
Zebra Technologies
ZBRA
|
+$1.32M |
| 3 |
SNCR
Synchronoss Technologies
SNCR
|
+$1.21M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$960K |
| 5 |
GE Aerospace
GE
|
+$820K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.05% |
| 2 | Financials | 17.09% |
| 3 | Technology | 12.24% |
| 4 | Healthcare | 9.78% |
| 5 | Communication Services | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Regeneron Pharmaceuticals
REGN
$68.8B
| $342K | 0.25% |
735
+15
| +2% | +$8.05K |
|
77
PayPal
PYPL
$49.5B
| $330K | 0.24% |
+10,632
| New | +$381K |
|
78
Healthpeak Properties
DOC
$15.4B
| $317K | 0.23% |
9,357
+778
| +9% | +$26.9K |
|
79
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
| $306K | 0.22% |
4,626
+14
| +0.3% | +$1.02K |
|
80
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $304K | 0.22% |
+3,815
| New | +$306K |
|
|
VAR
81
DELISTED
Varian Medical Systems, Inc.
VAR
| $295K | 0.22% |
4,562
| – | – |
|
82
IDEX
IEX
$16.5B
| $280K | 0.21% |
3,925
| – | – |
|
83
Wells Fargo
WFC
$261B
| $280K | 0.21% |
5,453
+152
| +3% | +$8.36K |
|
84
Intel
INTC
$466B
| $253K | 0.19% |
8,405
-5,884
| -41% | -$170K |
|
85
Emerson Electric
EMR
$82.9B
| $231K | 0.17% |
5,230
-4,325
| -45% | -$213K |
|
86
Chevron
CVX
$388B
| $229K | 0.17% |
2,900
-550
| -16% | -$46.3K |
|
87
Ford
F
$57.3B
| $164K | 0.12% |
12,113
-1,699
| -12% | -$24.3K |
|
|
FNFG
88
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $127K | 0.09% |
12,439
+34
| +0.3% | +$323 |
|
89
Akamai
AKAM
$16.8B
| – | – |
-8,920
| Closed | -$623K |
|
90
American Express
AXP
$223B
| – | – |
-2,645
| Closed | -$206K |
|
91
Baxter International
BAX
$11.6B
| – | – |
-7,088
| Closed | -$269K |
|
|
92
Gilead Sciences
GILD
$161B
| – | – |
-62,655
| Closed | -$7.34M |
|
|
SNCR
93
DELISTED
Synchronoss Technologies
SNCR
| – | – |
-2,942
| Closed | -$1.21M |
|
94
AT&T
T
$165B
| – | – |
-8,892
| Closed | -$239K |
|
|
95
iShares TIPS Bond ETF
TIP
$14.5B
| – | – |
-8,568
| Closed | -$960K |
|
96
State Street Technology Select Sector SPDR ETF
XLK
$115B
| – | – |
-10,760
| Closed | -$223K |
|
|
97
Zebra Technologies
ZBRA
$12.4B
| – | – |
-11,900
| Closed | -$1.32M |
|
|
CERN
98
DELISTED
Cerner Corp
CERN
| – | – |
-4,005
| Closed | -$277K |
|
Similar funds
EI
SAM
KC
TFA
WRPWM
WLIM
NI
CFO
Fagan Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Fagan Associates held 98 positions worth $136M, down 9% from $150M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Fagan Associates withdrew a net $6.34M in Q3 2015, closing 10 positions and reducing 26 holdings. Its most notable exit was Gilead Sciences, an estimated $7.34M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Fagan Associates opened a new position in Dollar General worth $1.05M.
- Fagan Associates's largest Q3 2015 buy was Dollar General: 14,570 shares worth $1.05M.
- Fagan Associates added most to Meta Platforms (Facebook) in Q3 2015, an estimated $1.09M increase.
- Fagan Associates's biggest Q3 2015 reduction was GE Aerospace, cutting an estimated $820K.
- Fagan Associates fully exited Gilead Sciences in Q3 2015, selling an estimated $7.34M.
- Fagan Associates's ten largest holdings make up 38% of its $136M portfolio in Q3 2015.
- Fagan Associates opened 5 new positions and closed 10 in Q3 2015.
- Fagan Associates's portfolio value fell 9% quarter-over-quarter to $136M.
Based on Fagan Associates's 13F filing for Q3 2015, filed 22 Oct 2015.